Learn from our successes on the journey to transforming the way complex patient care is delivered.
Search our resource library to discover information about Excelera Corp. and the Excelera Network. Results shown are based on dynamic filter selections and available resources.
This white paper describes the home infusion opportunity, outlines factors to consider in deciding whether to launch a home infusion program, and recommends resources. A case study describing an Excelera Home Infusion Solutions engagement is included. • Home infusion is a growing category. • Many health systems find that home infusion aligns with clinical and financial goals. • A consultant can help health systems get to market faster as they develop their in-house home infusion expertise.
Read MoreWolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
Read MoreUpdates include additions to the leadership team, enhanced technology platform capabilities to track electronic health record data and expanded product portfolio
Read MoreErin Kelley, PharmD, BCOP, and Jeff Engle, PharmD, MS, Fairview Health CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) is the most common type of leukemia in adults and accounts for approximately 37% of new leukemia cases. An estimated 20,720 new cases of and 3930 deaths from CLL will occur in the United States in 2019.
Read ArticleBy Don Amorosi, Chief Operating Officer; and Becky Rand, MHRM, Vice President of Manufacturer Relations ExceleraRx Corp Although the prevalence of health system-based specialty pharmacies has grown steadily over the past decade, 2020 will mark a critical year. Payers, providers, and health systems themselves are increasingly recognizing the important role integrated delivery solutions play in value-based care initiatives.
Read ArticleMeredith Holt joins Excelera with over 20 years of experience establishing and expanding health care initiatives, programs and relationships
Read MoreNew specialty pharmacy services and products, health system members and top executive hires highlight 2019 accomplishments
Read MoreAmanda Manoogian, PharmD, BCOP, Clinical Pharmacy Coordinator Specialty Pharmacy, Clinical Services, Partners Healthcare Hormone receptor-positive (HR-positive) breast cancer is the most common subtype of invasive breast cancer. Treatment has been focused on targeting the estrogen receptor pathway, and endocrine therapy (ET) has remained the mainstay treatment for these patients.
Read ArticleFor people living with cystic fibrosis, St. Luke’s is making it easier to keep up, by putting a pharmacy directly in the clinic. A new grant from the Cystic Fibrosis Foundation goes towards implementing a pharmacy program for the center in Boise.
Read ArticleSpecialty pharmacists within the Excelera Network continue to prove strong commitment to their trade
Read More